FRED KURLAND
CIK 1267273 · CFO · last filed 2023-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.78M
Companies
2
Total Filings
27
Lifetime Open-Market Net
-$200.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. (ARDS) Delisted | CFO | 4,000 | $0.31 | $1.2K | $0 | 7 | 2023-06-15 |
| XOMA | CFO & VP Finance | 114,461 | $41.79 | $4.78M | -$200.5K | 17 | 2015-04-07 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-04 | XOMA | Gift (G) | −16,000 | $0 | EDGAR |
| 2014-11-17 | XOMA | Mixed | +13,823 | -$34.1K | EDGAR |
| 2014-08-19 | XOMA | Mixed | +8,663 | -$44.8K | EDGAR |
| 2014-03-20 | XOMA | Mixed | +4,960 | -$37.4K | EDGAR |
| 2014-03-03 | XOMA | Grant (A) | +43,448 | $0 | EDGAR |
| 2014-02-10 | XOMA | Gift (G) | −7,639 | $0 | EDGAR |
| 2013-11-15 | XOMA | Mixed | +10,265 | -$48.2K | EDGAR |
| 2013-08-16 | XOMA | Mixed | −1,665 | -$29.0K | EDGAR |
| 2013-03-01 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2012-11-15 | XOMA | Mixed | +13,485 | -$23.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.